Wise Ally Introduces An Affordable Ventilator

My Subscriptions

Payment Confirmation

Transaction Failed

Your transaction failed, please try again or contact site support.

October 9, 2020

Wise Ally (Hong Kong) notes the COVID-19 pandemic is posing an unprecedented challenge to the world. Medical professionals and hospital workers across the globe are still struggling night and day to care for coronavirus patients.

Wise Ally also states while some patients might develop mild symptoms, however, there are 30%¹ of more severely infected patients have to stay in intensive care units supported by mechanical ventilators.

With over 35 million confirmed cases and 1 million deaths so far caused², ventilators have been in critical shortage globally since the beginning of the pandemic in late January 2020. There is an unmet need for rapidly deployable emergency-use ventilators with sufficient functionality to save patients with severe acute respiratory distress syndrome (ARDS).

In view of such distressing times, Wise Ally International Holdings Limited (Wise Ally) had decided to help save lives by developing the truly affordable and yet safe and easy-to-use ventilator – SapiVents which is built around a resuscitator bag usually found in ambulances and hospitals. SapiVents follows the strict guidance of Emergency Use Authorization under the FDA.

Its overall design, sensing technology and component selection is a major breakthrough in terms of cost by relying on a robust supply chain that is unlikely affected by shortages. It can certainly provide a temporary but crucial solution for emergency use offering basic ventilator functions during a critical situation.

Breathe Freely Campaign is a charitable initiative spearheaded by Wise Ally. With the generous funding from private and corporate donors and from the philanthropic sector, SapiVents is expected to undergo production and delivery by the end of 2020 to fight against COVID-19. At the production cost of less than US$300 each, not only SapiVents is by far the truly affordable non-invasive ventilator solution in the world, it will certainly ease up the pressure of hospitals in the most affected countries. All donations received will be used mainly on producing and delivering SapiVents via international NGOs and charity organizations.


Reference

  1. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
  2. WHO Coronavirus Disease (COVID-19) Dashboard
spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.